Role of iron in optimizing responses of anemic cancer patients to erythropoietin - The Glaspy/Cavill article reviewed

被引：0
|
作者：
Demetri, GD [1 ]
机构：
[1] Harvard Univ, Sch Med, Dana Farber Canc Inst, Ctr Sarcoma & Bone Oncol, Boston, MA 02115 USA
来源：
ONCOLOGY-NEW YORK | 1999年 / 13卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：484 / +
页数：2
相关论文
共 50 条
  • [41] Clarifying the Role of Neoadjuvant Therapy in Breast Cancer The Connolly/Stearns Article Reviewed
    Zelnak, Amelia
    ONCOLOGY-NEW YORK, 2010, 24 (02): : 149 - 149
  • [42] Effects of Preoperative Intravenous Erythropoietin Plus Iron on Outcome in Anemic Patients After Cardiac Valve Replacement
    Cladellas, Merce
    Farre, Nuria
    Comin-Colet, Josep
    Gomez, Miquel
    Merono, Oona
    Alba Bosch, M.
    Vila, Joan
    Molera, Rosa
    Segovia, Anna
    Bruguera, Jordi
    AMERICAN JOURNAL OF CARDIOLOGY, 2012, 110 (07): : 1021 - 1026
  • [43] FERRITIN AND IRON (FE) LEVELS IN ANEMIC HEMODIALYZED (HD) PATIENTS TREATED WITH ERYTHROPOIETIN (RHUEPO) AND DESFEROXAMINE (DFO)
    GARCIA, MJ
    MANJON, M
    GARCIAVALDECASAS, J
    NAVASPAREJO, A
    HERVAS, JG
    CEREZO, S
    KIDNEY INTERNATIONAL, 1993, 44 (06) : 1467 - 1467
  • [44] Apoptosis of erythroid progenitor cells in anemic patients with renal insufficiency. The role of erythropoietin (EPO).
    Oyake, T
    Ishida, Y
    Mizuno, T
    Yamauchi, F
    Hosokawa, H
    Kuriya, SI
    BLOOD, 1999, 94 (10) : 18B - 18B
  • [45] Iron supplement in cancer patients receiving erythropoietin - In reply
    Auerbach, M
    Ballard, H
    McIlwain, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (21) : 4428 - 4429
  • [46] Efficacy of IV Iron Compared to Oral Iron for Increment of Haemoglobin Level in Anemic Chronic Kidney Disease Patients on Erythropoietin Therapy
    Adhikary, L.
    Acharya, S.
    JOURNAL OF NEPAL MEDICAL ASSOCIATION, 2011, 51 (03) : 133 - 136
  • [47] Diagnosis of venous thromboembolic disease in cancer patients - The Gomes/Deitcher article reviewed
    Lohr, JM
    ONCOLOGY-NEW YORK, 2003, 17 (01): : 141 - 142
  • [48] Management of patients with cancer of unknown primary site - The Hainsworth/Greco article reviewed
    Lenzi, R
    Yalcin, S
    ONCOLOGY-NEW YORK, 2000, 14 (04): : 576 - +
  • [49] Prediction of response and other improvements on the limitations of recombinant human erythropoietin therapy in anemic cancer patients
    Beguin, Y
    HAEMATOLOGICA, 2002, 87 (11) : 1209 - 1221
  • [50] Pharmacology of antineoplastic agents in older cancer patients - The Lichtman/Skirvin article reviewed
    Aapro, MS
    ONCOLOGY-NEW YORK, 2000, 14 (12): : 1755 - +
12345